Historical Valuation
Medline Inc (MDLN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Medline Inc (MDLN) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：42.71
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Medline Inc (MDLN) has a current Price-to-Book (P/B) ratio of 42.33. Compared to its 3-year average P/B ratio of 41.76 , the current P/B ratio is approximately 1.37% higher. Relative to its 5-year average P/B ratio of 41.76, the current P/B ratio is about 1.37% higher. Medline Inc (MDLN) has a Forward Free Cash Flow (FCF) yield of approximately 2.98%. Compared to its 3-year average FCF yield of 3.10%, the current FCF yield is approximately -3.69% lower. Relative to its 5-year average FCF yield of 3.10% , the current FCF yield is about -3.69% lower.
Competitors Valuation Multiple
AI Analysis
The average P/S ratio for MDLN competitors is 3.96, providing a benchmark for relative valuation. Medline Inc Corp (MDLN.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis
1Y
3Y
5Y
Market capitalization of MDLN increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of MDLN in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is MDLN currently overvalued or undervalued?
Medline Inc (MDLN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Medline Inc (MDLN) is between to according to relative valuation methord.
What is Medline Inc (MDLN) fair value?
MDLN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Medline Inc (MDLN) is between to according to relative valuation methord.
How does MDLN's valuation metrics compare to the industry average?
The average P/S ratio for MDLN's competitors is 3.96, providing a benchmark for relative valuation. Medline Inc Corp (MDLN) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Medline Inc (MDLN) as of Jan 16 2026?
As of Jan 16 2026, Medline Inc (MDLN) has a P/B ratio of 42.33. This indicates that the market values MDLN at 42.33 times its book value.
What is the current FCF Yield for Medline Inc (MDLN) as of Jan 16 2026?
As of Jan 16 2026, Medline Inc (MDLN) has a FCF Yield of 2.98%. This means that for every dollar of Medline Inc’s market capitalization, the company generates 2.98 cents in free cash flow.
What is the current Forward P/E ratio for Medline Inc (MDLN) as of Jan 16 2026?
As of Jan 16 2026, Medline Inc (MDLN) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Medline Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Medline Inc (MDLN) as of Jan 16 2026?
As of Jan 16 2026, Medline Inc (MDLN) has a Forward P/S ratio of 0.00. This means the market is valuing MDLN at $0.00 for every dollar of expected revenue over the next 12 months.